Preclinical characterization and first-in-human administration of a selective monoacylglycerol Lipase inhibitor, ABX-1431 KU Leuven
Preclinical characterization and first-in-human administration of a selective monoacylglycerol lipase inhibitor, ABX-1431 Iain Fraser1*, Jacqueline Blankman1, Jason Clapper1, Cheryl Grice1, Gary O'Neill1, Alan Ezekowitz1, Archie Thurston2, Els Geenens3, Corinne Vandermeulen3 and Jan De Hoon3 1 Abide Therapeutics, N/A, United States 2 Seventh Wave Laboratories, N/A, United States 3 UZ Leuven, Center for Clinical Pharmacology, Belgium ...